Bleeding is not a common symptom of CML but when it occurs, it has been documented to be caused by the spread of leukemic cells, interferon-g (IFN-g) induced inhibitor of clotting factors or tyrosine kinase inhibitor agent-induced platelet dysfunction [4-8]. Here, IFNG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.